CND Life Sciences

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, CND Life Sciences sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,751 sponsors by registered trial count).

8 total trials 3 currently recruiting 1 completed upper quartile by trial count

CND Life Sciences: 8 sponsored US clinical trials, 3 recruiting.

CND Life Sciences sponsors 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Parkinson Disease, with 4 trials.

Upper-quartile sponsor footprint

CND Life Sciences sits in the upper quartile of the sponsor corpus (#1,604 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

8 total, page 1 of 1

RECRUITING

Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease

NCT07428447
RECRUITING

Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder

NCT07217054
RECRUITING

Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis

NCT07204652
ACTIVE NOT RECRUITING

Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease

NCT06621602
ACTIVE NOT RECRUITING

Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project

NCT07005947
ACTIVE NOT RECRUITING

The Syn-Sleep Study

NCT05757206
ACTIVE NOT RECRUITING

A Diagnostic Test for Dementia With Lewy Bodies

NCT05479552
COMPLETED

Synuclein-One Study

NCT04700722

Therapeutic Areas

Parkinson Disease 4
Parkinson 2
PARKINSON DISEASE (Disorder) 2
REM Sleep Behavior Disorder (iRBD) 1
Acute COVID-19 1
REM Behavior Disorder 1
MCI-DLB, Early Stage Dementia With Lewy Bodies 1
MCI-AD, Early Stage Alzheimer's Disease 1
Essential Tremor-plus 1
Parkinson s Disease 1

What is open in the CND Life Sciences pipeline

3 recruiting of 8 indexed (38% open); 1 completed (13%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Parkinson Disease (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Related

Compare saved trials side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.